Expertise in
9
conditions

Dr. Charles R. Dibb

Hematology Oncology
2828 E Barnett Rd, 
Medford, OR 
Expertise in
9
conditions
2828 E Barnett Rd, 
Medford, OR 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Charles Dibb is a Hematologist Oncology provider in Medford, Oregon. Dr. Dibb is highly rated in 9 conditions, according to our data. His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Non-Hodgkin Lymphoma, Virilizing Ovarian Tumor, and Ovarian Carcinosarcoma.

His clinical research consists of participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Hematology Oncology
Licenses
Internal Medicine in OR
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

2828 E Barnett Rd, Medford, OR 97504

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Randomized, Double-Blind Phase III Study of Pazopanib vs. Placebo in Patients With Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease Following Metastatectomy
Randomized, Double-Blind Phase III Study of Pazopanib vs. Placebo in Patients With Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease Following Metastatectomy
Enrollment Status: Active_not_recruiting
Publish Date: September 22, 2025
Intervention Type: Procedure, Drug, Other
Study Drug: Pazopanib Hydrochloride
Study Phase: Phase 3
A Randomized Phase II/III Trial of Afatinib Plus Cetuximab Versus Afatinib Alone in Treatment-Naive Patients With Advanced, EGFR Mutation Positive Non-small Cell Lung Cancer (NSCLC)
A Randomized Phase II/III Trial of Afatinib Plus Cetuximab Versus Afatinib Alone in Treatment-Naive Patients With Advanced, EGFR Mutation Positive Non-small Cell Lung Cancer (NSCLC)
Enrollment Status: Active_not_recruiting
Publish Date: September 18, 2025
Intervention Type: Drug, Other, Biological
Study Drugs: Afatinib Dimaleate, Cetuximab
Study Phase: Phase 2/Phase 3
Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive and HER2/Neu Negative Breast Cancer
Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive and HER2/Neu Negative Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: December 27, 2024
Intervention Type: Drug, Other
Study Drugs: Anastrozole, Everolimus, Exemestane, Goserelin Acetate, Letrozole, Leuprolide Acetate, Tamoxifen Citrate
Study Phase: Phase 3
A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel With or Without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer
A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel With or Without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: June 03, 2024
Intervention Type: Drug, Other
Study Drugs: Carboplatin, Cyclophosphamide, Doxorubicin Hydrochloride, Paclitaxel
Study Phase: Phase 3
View 3 Less Clinical Trials
Similar Doctors
Expertise in
60
conditions
Dr. Mujahid A. Rizvi
Hematology Oncology | Hematology | Oncology
Expertise in
60
conditions
Dr. Mujahid A. Rizvi
Hematology Oncology | Hematology | Oncology

Asante

2825 E Barnett Rd, 
Medford, OR 
 (0.2 miles away)
541-789-7000
Languages Spoken:
English, Hindi, Urdu
See accepted insurances
Accepting New Patients
Offers Telehealth

Mujahid Rizvi is a Hematologist Oncology specialist and a Hematologist in Medford, Oregon. Dr. Rizvi is highly rated in 60 conditions, according to our data. His top areas of expertise are Appendix Cancer, Reticuloendotheliosis, Hairy Cell Leukemia (HCL), Lynch Syndrome, and Bone Marrow Aspiration. Dr. Rizvi is currently accepting new patients.

Expertise in
36
conditions
Dr. Sandra J. Taylor
Hematology Oncology | Hematology | Oncology
Expertise in
36
conditions
Dr. Sandra J. Taylor
Hematology Oncology | Hematology | Oncology

Asante

2825 E Barnett Rd, 
Medford, OR 
 (0.2 miles away)
541-789-7000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Sandra Taylor is a Hematologist Oncology specialist and a Hematologist in Medford, Oregon. Dr. Taylor is highly rated in 36 conditions, according to our data. Her top areas of expertise are Colorectal Cancer, Desmoplastic Small Round Cell Tumor, Chronic Lymphocytic Leukemia (CLL), and Familial Colorectal Cancer. Dr. Taylor is currently accepting new patients.

Expertise in
17
conditions
Dr. Susan E. Kohler
Hematology Oncology
Expertise in
17
conditions
Dr. Susan E. Kohler
Hematology Oncology
2828 E Barnett Rd, 
Medford, OR 
 (0.1 miles away)
541-774-5853
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Susan Kohler is a Hematologist Oncology provider in Medford, Oregon. Dr. Kohler is highly rated in 17 conditions, according to our data. Her top areas of expertise are Breast Cancer, Thrombocytopenia, Paget Disease of the Breast, and Gaucher Disease Type 3. Dr. Kohler is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Dibb's expertise for a condition
ConditionClose
      View All 9 Advanced Conditions
      View All 47 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile